STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023
HORSHAM, Pa. , March 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth
STRATA Skin Sciences Affirms No Exposure to Silicon Valley Bank
HORSHAM, Pa. , March 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it does not have exposure to Silicon
STRATA Skin Sciences Announces the Launch of New, Patient-Focused XTRAC® Website
Website delivers enhanced patient resources including an easy 3-step process to search, find, and communicate directly with XTRAC partner practices HORSHAM, Pa. , March 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,
HORSHAM, Pa. , Feb. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it had been notified by Nasdaq that
HORSHAM, Pa. , Feb. 16, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Joel L.
STRATA Skin Sciences Expects Record Full Year 2022 Revenue
Unaudited, preliminary revenue within the range of $35-$36 million Record revenue represents approximately 17-19% growth over full year 2021 HORSHAM, Pa. , Feb. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,
All patients experienced a visible reduction in acne lesions HORSHAM, Pa. , Jan. 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences Expands into $300 Million Market with Exclusive Distribution Agreement in Mexico
HORSHAM, Pa. , Jan. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an exclusive agreement with MINO Labs , a